Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Push Health vs T2D.com

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #383Desk pick
Push Health

Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network.

Marked down on: Brand-name-only — no compounded option

vs
Dispatch #422
T2D.com

T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

Marked down on: No pricing published on the public website — must register to see costs

Push Health takes this head-to-head with the higher Desk Score, 54/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Push Health

54/100

C

Overall

T2D.com

51/100

C

Price transparency

38
30

State access

24
42

Molecule range

66
66

Onboarding speed

74
56

Support responsiveness

71
70

Licensing & trust

79
68

The spec sheet

FieldPush HealthT2D.com
Semaglutide$950/mo (brand-name)$999/mo (starting dose, compounded)
TirzepatideNot disclosed$999/mo (starting dose, compounded)
CoverageCoverage not published1 state
Brand-nameYesCompounded only
Oral optionInjectable onlyInjectable only
Best forReaders who want brand-name GLP-1 distribution via large pharmacy network (pending verification).Readers who want diabetic GLP-1 access.
Desk Score54/100C51/100C

The verdict

Desk pick — Push Health

Push Health takes this head-to-head with the higher Desk Score, 54/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.

Choose Push Health if…

Readers who want brand-name GLP-1 distribution via large pharmacy network (pending verification).

$950/mo (brand-name) sema · Not disclosed tirz · Coverage not published

Choose T2D.com if…

Readers who want diabetic GLP-1 access.

$999/mo (starting dose, compounded) sema · $999/mo (starting dose, compounded) tirz · 1 state

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Push Health · T2D.com.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.